About US
Contact us
-
Merck’s Investigational Grass Sublingual Allergy Immunotherapy Tablet Significantly Reduced Allergy Symptoms in Pivotal Phase III StudyMerck, known as MSD outside the US and Canada,has announced data for its investigational Timothy grass sublingual allergy immunotherapy tablet (MK-7243) from a study involving 1501 North American adul2013/11/12
-
Advaxis's cancer vaccine gets FDA orphan status for treatment of HPV-associated head and neck cancerUS-based clinical-stage biotechnology firm Advaxis has received orphan drug designation from the US Food and Drug Administration (FDA) for its lead drug candidate ADXS-HPV to treat human papillomaviru2013/11/11
-
Alzheimer'​s Disease Market to Witness Slight Increase by 2019As a result of Phase III therapy LMTX potentially entering the Alzheimer’s Disease (AD) industry in the near future, the AD market will increase slightly from $3.6 billion in 2012 to $3.8 billion in 22013/11/11
-
Gastro specialist Salix nabs Santarus and new colitis drug in $2.6B dealSalix Pharmaceuticals, the gastrointestinal drug specialist, has snapped up fellow specialty drugmaker Santarus in a $2.6 billion all-cash buyout. The deal will add a clutch of Santarus products to S2013/11/8
-
Bayer envisions bigger Eylea market with new EU useBayerhas taken another step toward fulfilling blockbuster ambitions for its eye drugEylea. The German drugmaker asked European regulators to approve the vision-loss treatment for patients with diabeti2013/11/8
-
Januvia's Q3 Performanc​e Proves Importance of Business Strategy for Type 2 Diabetes DrugsFollowing what was once the rising success of Merck’s first-to-market DPP-4 inhibitor, Januvia, which achieved significant sales of $4 billion in 2012, the unexpectedly poor performance of the type 22013/11/7
-
Novartis plots sales cuts in U.K. amid R&D restructuringNovartis ($NVS) has brought its job-cutting sword to the U.K., with plans to shutter an R&D site in Horsham. Up to 371 jobs are expected to disappear there. But that's not all. The Swiss drugmaker2013/11/7
-
Capsugel Completes Acquisition of Bend ResearchMORRISTOWN, N.J. – Capsugel announced today that it has completed its acquisition of Bend Research Inc., a recognized industry leader in bioavailability enhancement. Bend Research is now part of Capsu2013/11/6
-
Merck Millipore Launches Lockable ICRplus Settle Plates for Safe and Efficient Viable Air Monitoring and Personnel MonitoringMerck Millipore, the Life Science division of Merck, has launched lockable ICRplus Settle Plates for viable air monitoring and personnel monitoring in clean rooms and isolators. The new plates are2013/11/6
-
Aesica Introduces Aseptic Micro Dosing Capabilities at Nottingham SiteAesica,a global contract development and manufacturing organisation (CDMO), has introduced 3P’s Fill2Weight dispensing system — suitable for all powder formulations including spray dried and lyophilis2013/11/5